hemocoagulase atrox
Commercial- Indications
- Perioperative blood loss
Company intelligence / Profile preview
The name "Liaoning Oriental Pharmaceutical" does not appear as an exact standalone entity in available records. However, the broader pharmaceutical sector in Liaoning province includes several active manufacturers of generic drugs and APIs. These companies are involved in R&D and production, with some being targets for acquisition by multinational corporations, contributing to a growing biopharma industrial cluster.
3 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Liaoning Oriental Pharmaceutical.